Evaluation of right ventricular function in acute pulmonary embolism by 3D ejection fraction and longitudinal strain echocardiography in acute phase and follow-up

医学 射血分数 肺栓塞 内科学 心脏病学 危险分层 不利影响 心室功能 多普勒超声心动图 心力衰竭 血压 舒张期
作者
N Ramos Lopez,P Mahia,Fabián Islas Ramírez,Carlos Ferrera,D Enriquez Vazquez,T Luque Diaz,Fuencisla Sanz,J.A.F Abelaira Freire,Manuel Serrano,Javier Higueras,L.G.H Galvan Herraez,José María Pedrajas,Antonio Fernández-Ortı́z,Pablo Salinas Sanguino,Carlos Macaya
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:42 (Supplement_1)
标识
DOI:10.1093/eurheartj/ehab724.079
摘要

Abstract Background Assessment of right ventricular (RV) function by transthoracic echocardiography (TTE) in acute pulmonary embolism (PE) has an essential role to severity stratification. However, there is no reliable information on RV function about the clinical utility of advanced TTE parameters in follow-up. Purpose We aimed to assess the clinical utility of 3D RV ejection fraction (3DEF) and free wall longitudinal strain (FWLS) compared to conventional parameters in evaluating RV function in patients with acute PE at time of diagnosis and after follow-up and the relation with adverse outcomes. Methods We prospectively recruited 86 patients with intermediate-high and high-risk bilateral PE from 2018 to 2020 in our centre. Patients underwent TTE during admission and at 6 to 12 months follow-up that included conventional RV parameters (pulsed Doppler S wave (S'), TAPSE, and fractional area change (FAC)). 3DEF and FWLS were obtained as well. Normal values were stablished according to European guidelines. Results Mean age was 63.7±16.5 years, 58% males. Reperfusion treatment was performed in a 26,8%. In-hospital mortality was 4,7% (3 patients in the acute phase of PE and 1 due to rePE. The median follow-up was 1.3 years (IQR 1–2.5). 9 patients died (2 due to PE, 3 due to respiratory failure and 5 due to cancer). Patients with adverse events had a greater severity in PESI scale and worse RV function assessed by 3DEF and 3D volumes. There were no significant differences between groups in FAC, S' and TAPSE (Table 1). Baseline echocardiographic parameters were analyzed in the acute phase during admission and at 6–12 month follow-up (Table 2). There was a significant improvement in conventional parameters (TAPSE and FAC) and a reversal of FWLS values (P=0,01) at follow-up. 3DEF improved, but was not statistically significant (p=0,06). There was a greater reversal in end-systolic volume compared to end-diastolic volume. Conclusion Advanced RV function assessment by 3DEF and FWLS is useful in the acute phase and follow-up. FWLS showed and early normalization after PE resolution, whereas 3DEF improved but remained pathological at 6–12 months follow-up. Funding Acknowledgement Type of funding sources: None. Table 1Table 2

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
何昆朋发布了新的文献求助10
刚刚
1秒前
兔宝宝发布了新的文献求助10
1秒前
科研通AI6.1应助keyan采纳,获得10
2秒前
量子星尘发布了新的文献求助10
2秒前
4秒前
Pull发布了新的文献求助10
4秒前
Annie发布了新的文献求助10
5秒前
学霸业完成签到,获得积分10
5秒前
量子星尘发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
CipherSage应助兔宝宝采纳,获得10
9秒前
9秒前
个性枕头完成签到 ,获得积分10
11秒前
萱萱完成签到,获得积分10
12秒前
梦在彼岸发布了新的文献求助10
12秒前
13秒前
Jackpu完成签到,获得积分10
14秒前
萝卜完成签到,获得积分10
15秒前
wmm完成签到,获得积分10
16秒前
孤独梦曼完成签到,获得积分10
16秒前
爆米花应助刻苦冬菱采纳,获得10
16秒前
17秒前
17秒前
Annie完成签到,获得积分10
17秒前
18秒前
19秒前
断章完成签到 ,获得积分10
20秒前
风中的又蓝完成签到,获得积分10
20秒前
Patrick完成签到 ,获得积分10
21秒前
21秒前
21秒前
23秒前
打打应助徐山淇采纳,获得10
23秒前
23秒前
zihailing完成签到,获得积分20
24秒前
24秒前
25秒前
高分求助中
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 40000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Ägyptische Geschichte der 21.–30. Dynastie 2500
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
„Semitische Wissenschaften“? 1510
从k到英国情人 1500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5742911
求助须知:如何正确求助?哪些是违规求助? 5411336
关于积分的说明 15346296
捐赠科研通 4883960
什么是DOI,文献DOI怎么找? 2625453
邀请新用户注册赠送积分活动 1574294
关于科研通互助平台的介绍 1531234